Novartis India [NOVARTIND] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Novartis India Ltd.

BSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Novartis India Ltd. wins in 10 metrics, Divi's Laboratories Ltd. wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Novartis India Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 25.00 67.11 Novartis India Ltd.
Price-to-Book Ratio 3.14 10.82 Novartis India Ltd.
Debt-to-Equity Ratio 0.52 0.58 Novartis India Ltd.
PEG Ratio -1.18 4.63 Divi's Laboratories Ltd.
EV/EBITDA 20.21 48.63 Novartis India Ltd.
Profit Margin (TTM) 27.97% 24.04% Novartis India Ltd.
Operating Margin (TTM) 25.47% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 25.47% 29.65% Divi's Laboratories Ltd.
Return on Equity 12.85% 14.64% Divi's Laboratories Ltd.
Return on Assets (TTM) 10.65% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $745.70M $2.15B Divi's Laboratories Ltd.
Dividend Yield 2.44% 0.91% Novartis India Ltd.
1-Year Return 49.33% 0.83% Novartis India Ltd.
Price-to-Sales Ratio (TTM) 7.00 16.18 Novartis India Ltd.
Enterprise Value $18.37B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 5.29 15.86 Novartis India Ltd.
Gross Profit Margin (TTM) 43.07% 63.71% Divi's Laboratories Ltd.
Revenue per Share (TTM) $141 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $39.42 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) -0.05 0.19 Novartis India Ltd.

Novartis India Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

NOVARTIND
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Novartis India Ltd.-9.47%-10.87%29.78%44.07%63.91%70.30%
Divi's Laboratories Ltd.0.67%-3.25%-0.65%4.12%1.88%3.66%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Novartis India Ltd.49.33%115.71%137.09%117.42%110.10%222.44%
Divi's Laboratories Ltd.0.83%89.86%56.44%484.44%1,625.50%9,907.51%

Performance & Financial Health Analysis: Novartis India Ltd. vs Divi's Laboratories Ltd.

MetricNOVARTINDDIVISLAB
Market Information
Market Cap i₹23.65B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i10,693253,443
90 Day Avg. Volume i14,037283,911
Last Close₹1,326.20₹6,576.50
52 Week Range₹750.00 - ₹1,588.40₹5,636.50 - ₹7,071.50
% from 52W High-16.51%-7.00%
All-Time High₹1,588.40 (Jun 01, 2026)₹7,071.50 (Jul 08, 2025)
% from All-Time High-16.51%-7.00%
Growth Metrics
Quarterly Revenue Growth-0.08%0.12%
Quarterly Earnings Growth-0.37%-0.01%
Financial Health
Profit Margin (TTM) i0.28%0.24%
Operating Margin (TTM) i0.25%0.30%
Return on Equity (TTM) i0.13%0.15%
Debt to Equity (MRQ) i0.520.58
Cash & Liquidity
Book Value per Share (MRQ)₹313.93₹580.95
Cash per Share (MRQ)₹250.14₹122.95
Operating Cash Flow (TTM) i₹997.00M₹19.67B
Levered Free Cash Flow (TTM) i₹1.01B₹21.91B
Dividends
Last 12-Month Dividend Yield i2.44%0.91%
Last 12-Month Dividend i₹25.00₹60.00

Valuation & Enterprise Metrics Analysis: Novartis India Ltd. vs Divi's Laboratories Ltd.

MetricNOVARTIND (Apr 24, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i25.0067.11
Forward P/E iN/A53.75
PEG Ratio i-1.184.63
Price to Sales (TTM) i7.0016.18
Price to Book (MRQ) i3.1410.82
Market Capitalization
Market Capitalization i₹23.65B₹1.69T
Enterprise Value i₹18.37B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i5.2915.86
Enterprise to EBITDA i20.2148.63
Risk & Other Metrics
Beta i-0.050.19
Book Value per Share (MRQ) i₹313.93₹580.95

Financial Statements Comparison: Novartis India Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricNOVARTIND (2025)DIVISLAB (2025)
Revenue/Sales i3.56B93.25B
Cost of Goods Sold i2.06B38.70B
COGS % of Revenue i57.7%41.5%
Gross Profit i1.51B54.55B
Gross Margin i42.3%58.5%
Research & Development iN/A270.00M
Operating Income (EBIT) i941.70M25.71B
Operating Margin i26.4%27.6%
EBITDA i1.38B33.19B
EBITDA Margin i38.7%35.6%
Pre-Tax Income i1.30B29.16B
Pre-Tax Income % of Revenue i36.6%31.3%
Income Tax i295.20M7.25B
Income Tax % of Revenue i8.3%7.8%
Net Income (Profit) i1.01B21.91B
Profit Margin i28.3%23.5%

Balance Sheet & Liquidity Metrics

MetricNOVARTIND (2025)DIVISLAB (2025)
Cash & Equivalents i520.70M4.15B
Total Current Assets i7.46B100.81B
Total Current Assets % of Revenue i209.3%108.1%
Total Current Liabilities i1.42B14.52B
Total Current Liabilities % of Revenue i39.9%15.6%
Long-Term Debt i32.10M20.00M
Long-Term Debt % of Revenue i0.9%0.0%
Total Shareholders Equity i7.85B149.69B
Retained Earnings i7.69B134.00B
Retained Earnings % of Revenue i215.8%143.7%
Property, Plant & Equipment i35.70M3.19B

Cash Flow Statement Comparison

MetricNOVARTIND (2025)DIVISLAB (2025)
Operating Cash Flow i997.00M19.67B
Operating Cash Flow % of Revenue i28.0%21.1%
Capital Expenditures i3.20M-14.38B
Free Cash Flow i745.70M2.15B
FCF Margin i20.9%2.3%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricNOVARTINDDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i24.69M265.47M
Float Shares i6.69M117.72M
% Held by Insiders i72.92%52.04%
% Held by Institutions i0.16%28.65%
% Held by Public i26.92%19.31%

Dividend Analysis & Yield Comparison: Novartis India Ltd. vs Divi's Laboratories Ltd.

MetricNOVARTINDDIVISLAB
Last 12-Month Dividend i₹25.00₹60.00
Last 12-Month Dividend Yield i2.44%0.91%
3-Year Avg Annual Dividend i₹32.50₹50.00
3-Year Avg Dividend Yield i3.57%0.70%
3-Year Total Dividends i₹97.50₹150.00
Ex-Dividend DateJul 23, 2025Jul 25, 2025